New antibiotics for selective treatment of gastrointestinal infection caused byClostridium difficile
出版年份 2010 全文链接
标题
New antibiotics for selective treatment of gastrointestinal infection caused byClostridium difficile
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 20, Issue 10, Pages 1389-1399
出版商
Informa Healthcare
发表日期
2010-08-11
DOI
10.1517/13543776.2010.511177
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- National point prevalence of Clostridium difficile in US health care facility inpatients, 2008
- (2009) William R. Jarvis et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection
- (2009) D.M. Citron et al. ANAEROBE
- Nitazoxanide versus Vancomycin inClostridium difficileInfection: A Randomized, Double‐Blind Study
- (2009) Daniel M. Musher et al. CLINICAL INFECTIOUS DISEASES
- Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections
- (2009) I. A. Critchley et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria
- (2009) D. M. Citron et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model
- (2009) U. A. Ochsner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes
- (2009) Stuart Johnson JOURNAL OF INFECTION
- In Vitro Activity of OPT-80 Tested against Clinical Isolates of Toxin-Producing Clostridium difficile
- (2008) J. A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety, Tolerance, and Pharmacokinetic Studies of OPT-80 in Healthy Volunteers following Single and Multiple Oral Doses
- (2008) Y. K. Shue et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Outcomes, Safety, and Pharmacokinetics of OPT-80 in a Phase 2 Trial with Patients with Clostridium difficile Infection
- (2008) T. Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rising Economic Impact of Clostridium difficile-Associated Disease in Adult Hospitalized Patient Population
- (2008) Xiaoyan Song et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin
- (2008) R. O'Connor et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?
- (2008) J. M. Blondeau JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of reduced susceptibility to metronidazole in Clostridium difficile
- (2008) S. D. Baines et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model
- (2008) S. D. Baines et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A case-control study of community-associated Clostridium difficile infection
- (2008) M. H. Wilcox et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started